ZT
Zhude Tu
Principal Investigator
Washington University in St. Louis
I'm working on
8 months ago
Radiopharmaceuticals, PET Imaging, Medicinal Chemistry, Neuroinflammation
About
Zhude Tu advances PET radiotracers from discovery to first-in-human studies. Portfolio spans VAChT and S1P receptor imaging agents, supported by NIH R01s (~$7.7M). Holds an issued S1PR1 imaging patent and a provisional S1PR2 filing.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.